Gamble Jones Investment Counsel’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $12.3M | Sell |
239,082
-5,225
| -2% | -$251K | 0.92% | 26 |
|
|
2022
Q3 | $10.7M | Sell |
244,307
-510
| -0.2% | -$24.8K | 0.87% | 28 |
|
|
2022
Q2 | $12.8M | Sell |
244,817
-4,807
| -2% | -$245K | 0.95% | 23 |
|
|
2022
Q1 | $12.9M | Sell |
249,624
-1,505
| -0.6% | -$78.1K | 0.81% | 29 |
|
|
2021
Q4 | $14.8M | Sell |
251,129
-1,693
| -0.7% | -$83.9K | 0.88% | 23 |
|
|
2021
Q3 | $10.9M | Sell |
252,822
-1,355
| -0.5% | -$60K | 0.71% | 33 |
|
|
2021
Q2 | $9.95M | Sell |
254,177
-1,649
| -0.6% | -$64.1K | 0.65% | 37 |
|
|
2021
Q1 | $9.27M | Sell |
255,826
-10,948
| -4% | -$389K | 0.62% | 39 |
|
|
2020
Q4 | $9.82M | Sell |
266,774
-46,252
| -15% | -$1.7M | 0.67% | 35 |
|
|
2020
Q3 | $10.9M | Buy |
313,026
+6,191
| +2% | +$217K | 0.79% | 32 |
|
|
2020
Q2 | $9.52M | Sell |
306,835
-237
| -0.1% | -$8.05K | 0.76% | 32 |
|
|
2020
Q1 | $9.51M | Sell |
307,072
-1,715
| -0.6% | -$58.4K | 0.88% | 29 |
|
|
2019
Q4 | $11.5M | Buy |
308,787
+6,792
| +2% | +$242K | 0.9% | 31 |
|
|
2019
Q3 | $10.3M | Sell |
301,995
-8,916
| -3% | -$324K | 0.85% | 31 |
|
|
2019
Q2 | $12.8M | Sell |
310,911
-6,184
| -2% | -$246K | 1.09% | 23 |
|
|
2019
Q1 | $12.8M | Sell |
317,095
-1,204
| -0.4% | -$48.2K | 1.13% | 22 |
|
|
2018
Q4 | $13.2M | Sell |
318,299
-2,216
| -0.7% | -$92K | 1.33% | 15 |
|
|
2018
Q3 | $13.4M | Sell |
320,515
-11,458
| -3% | -$441K | 1.24% | 17 |
|
|
2018
Q2 | $11.4M | Sell |
331,973
-228,164
| -41% | -$7.8M | 1.15% | 18 |
|
|
2018
Q1 | $18.9M | Sell |
560,137
-989
| -0.2% | -$34K | 1.88% | 8 |
|
|
2017
Q4 | $19.3M | Sell |
561,126
-2,842
| -0.5% | -$96.9K | 1.83% | 8 |
|
|
2017
Q3 | $19.1M | Sell |
563,968
-22,808
| -4% | -$733K | 1.96% | 7 |
|
|
2017
Q2 | $18.7M | Buy |
586,776
+2,570
| +0.4% | +$81K | 1.96% | 7 |
|
|
2017
Q1 | $19M | Sell |
584,206
-9,240
| -2% | -$291K | 2% | 7 |
|
|
2016
Q4 | $18.3M | Sell |
593,446
-4,053
| -0.7% | -$124K | 2.03% | 7 |
|
|
2016
Q3 | $19.2M | Sell |
597,499
-4,494
| -0.7% | -$150K | 2.08% | 7 |
|
|
2016
Q2 | $20.1M | Sell |
601,993
-88
| -0% | -$2.81K | 2.19% | 7 |
|
|
2016
Q1 | $16.9M | Buy |
602,081
+12,359
| +2% | +$353K | 1.88% | 8 |
|
|
2015
Q4 | $18.1M | Sell |
589,722
-3,863
| -0.7% | -$122K | 1.99% | 7 |
|
|
2015
Q3 | $17.7M | Sell |
593,585
-14,753
| -2% | -$473K | 2.04% | 7 |
|
|
2015
Q2 | $19.4M | Sell |
608,338
-11,953
| -2% | -$390K | 2.01% | 9 |
|
|
2015
Q1 | $20.5M | Sell |
620,291
-11,159
| -2% | -$355K | 2.13% | 6 |
|
|
2014
Q4 | $18.7M | Buy |
631,450
+12,829
| +2% | +$368K | 1.93% | 7 |
|
|
2014
Q3 | $17.4M | Buy |
618,621
+1,128
| +0.2% | +$31.7K | 1.92% | 7 |
|
|
2014
Q2 | $17.4M | Buy |
617,493
+45,526
| +8% | +$1.3M | 1.94% | 6 |
|
|
2014
Q1 | $17.4M | Buy |
571,967
+11,098
| +2% | +$331K | 2.03% | 6 |
|
|
2013
Q4 | $16.3M | Buy |
560,869
+18,670
| +3% | +$543K | 1.92% | 6 |
|
|
2013
Q3 | $14.8M | Sell |
542,199
-4,971
| -0.9% | -$135K | 1.9% | 6 |
|
|
2013
Q2 | $14.5M | Buy |
+547,170
| New | +$15.1M | 1.92% | 4 |
|
Other funds holding PFE
AWA
Gamble Jones Investment Counsel's PFE Position: Q4 2022 in Review
Gamble Jones Investment Counsel reduced its Pfizer (PFE) stake by 2.1% in Q4 2022, selling an estimated $251K and leaving 239,082 shares worth $12.3M. The position accounts for 0.92% of the portfolio, ranked #26.
Gamble Jones Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 39 quarters since. The position peaked at $20.5M in Q1 2015. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.
- Gamble Jones Investment Counsel held 239,082 shares of Pfizer worth $12.3M as of Q4 2022.
- Gamble Jones Investment Counsel sold 5,225 Pfizer shares in Q4 2022, an estimated $251K.
- Pfizer made up 0.92% of Gamble Jones Investment Counsel's portfolio in Q4 2022, its #26 holding.
- Gamble Jones Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 39 quarters since.
- Gamble Jones Investment Counsel's Pfizer position peaked at $20.5M in Q1 2015.
- 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.
Based on Gamble Jones Investment Counsel's 13F filing for Q4 2022, filed 8 Feb 2023.